Last $127.96 USD
Change Today +3.62 / 2.91%
Volume 3.1M
As of 1:23 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

81 Wyman Street

Waltham, MA 02451

United States

Phone: 781-622-1000

Fax: 781-622-1207

iotechnology and diagnostic industries. Custom services are also available for media and feed formulation media optimization, analytical services, production method development and optimization, rapid prototyping, and supply chain management. SPECIALTY DIAGNOSTICS This segment offers a range of diagnostic test kits, reagents, culture media, instruments, and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. This segment has six primary businesses, including immunodiagnostics, clinical diagnostics, transplant diagnostics, microbiology, anatomical pathology, and its healthcare market channel. ImmunoDiagnostics The company’s immunodiagnostics offerings include developing, manufacturing, and marketing blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases. Unlike skin prick tests, the company’s in vitro allergy diagnostic tests utilize flexible systems, which provide for allergy diagnoses on low and high-throughput automation. In addition, it could offer antibody tests for approximately 20 indications to help diagnose autoimmune diseases, such as rheumatoid arthritis, celiac disease, lupus, and scleroderma. These allergy and autoimmunity product lines operate on a common instrument platform, which supports both productivity and cost efficiencies in clinical laboratories worldwide. Its products include ImmunoCAP for allergy and asthma tests and EliA for autoimmunity tests. Clinical Diagnostics The company’s clinical diagnostics products include an offering of liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids. In particular, the company provides products used for drugs-of-abuse testing; therapeutic drug monitoring, including immunosuppressant drug testing; thyroid hormone testing; serum toxicology; clinical chemistry; immunology; hematology; coagulation; glucose tolerance testing; first trimester screening; tumor markers testing; and biomarkers testing for sepsis, acute myocardial infarction, and congestive heart failure. The company also private labels majority of its reagents and controls for major in vitro diagnostics companies through OEM arrangements. In various instances, the company would work with customers or partners to develop new products and applications for their instrument platforms. The company has developed a menu for drugs-of-abuse immunoassays. It also offers a line of immunosuppressant drug immunoassays that could be used on various clinical chemistry analyzers. The company’s clinical chemistry systems include analyzers and reagents to analyze and measure routine blood and urine chemistry, such as glucose and cholesterol; and advanced testing for specific proteins, therapeutic drug monitoring, and drugs-of-abuse. Its diagnostic test range covers approximately 80 different validated methods. The company also provides pre- and post-analytical automation for preparation of blood specimens before and after analysis, and specialty diagnostic tests based on patented biomarkers for sepsis, cardiovascular, and pulmonary diseases, as well as intensive care treatments and prenatal screening. Transplant Diagnostics With the company’s acquisition of One Lambda, Inc., it engages in human leukocyte antigen (HLA) typing and testing for the organ transplant market. The company’s diagnostic tests are used by transplant centers for tissue typing, primarily to determine the compatibility of donors and recipients pre-transplant, and to detect the presence of antibodies post-transplant that could lead to transplant rejection. These transplant diagnostic tests are used across the transplant-testing workflow to improve patient outcomes. Its transplant diagnostic offerings include various lines of HLA typing and antibody detection assays utilizing serological, molecular, ELISA, flow, and Luminex xMAP technologies. Microbiology The company’s microbiology offerings include dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TMO:US $127.96 USD +3.62

TMO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akzo Nobel NV €64.28 EUR +0.42
Becton Dickinson and Co $139.76 USD -1.06
Corning Inc $23.58 USD -0.64
Danaher Corp $82.84 USD -0.01
Safran SA €59.74 EUR +0.45
View Industry Companies
 

Industry Analysis

TMO

Industry Average

Valuation TMO Industry Range
Price/Earnings 30.0x
Price/Sales 3.1x
Price/Book 2.4x
Price/Cash Flow 30.4x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERMO FISHER SCIENTIFIC INC, please visit www.thermofisher.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.